Maine Invokana Lawyer
Over 29 million Americans (or 10% of the U.S. population) currently suffer from diabetes. And it is estimated that 1 of every 3 people will develop diabetes during their lifetime.
With diabetes becoming a major health problem, medications used to treat the disease is big business for pharmaceutical companies.
One of these new medications, Invokana, was rushed to the market to reap huge profits for the manufacturer. Recent studies link Invokana to serious side effects including amputations of the leg, foot and finger, and diabetic ketoacidosis.
What is Invokana & How Does It Work?
Invokana (canagliflozin) is used to lower blood sugar in persons with Type 2 or “adult onset” diabetes. The drug is in a class of medications called sodium-glucose cotransporter 2 inhibitors (“SGLT2 inhibitors”) and is also sold in combination with metformin under the brand name Invokamet. Invokana is designed and marketed by Janssen Pharmaceuticals (“Janssen”), a subsidiary of Johnson & Johnson.
Type 2 diabetes occurs when the human body produces enough insulin, but cannot use insulin properly resulting in high blood sugar levels which can lead to long-term health problems. Invokana works to lower the body’s blood sugar levels by stopping the kidneys from reabsorbing glucose. Instead of the glucose remaining in the body, it is excreted from the body in urine.
What Injuries Are Associated with Invokana?
Patients who use Invokana are at risk of numerous serious side effects, including:
- Amputation of the foot, leg or finger
- Diabetic ketoacidosis
- Renal failure and acute kidney injury
- Urinary tract infections, resulting in either blood or kidney infections
Unfortunately, some Invokana-related injuries can become so severe that they result in death or permanent disability.
Regulatory Oversight of Invokana
Even though the drug has not been on the market very long, Invokana has already been the subject of several safety notifications from the U.S. Food and Drug Administration (“FDA”), including:
- May 2015: the FDA issued a Drug Safety Communication warning that Invokana is associated with an increased risk of diabetic ketoacidosis, which is a serious complication of diabetes where the body produces high levels of blood acids which can be life-threatening.
- September 2015: the FDA issued another Drug Safety Communication concerning the risk of bone fractures due to decreased bone density.
- December 2015: the FDA released another Drug Safety Communication requiring an update to the drug’s prescribing information to containing new warnings about the risks of diabetic ketoacidosis and urinary tract infections.
- May 2017: the FDA issued a fourth Drug Safety Communications requiring a “black box” warning about the increased risk of leg and foot amputations with Invokana use.
A growing number of Invokana lawsuits are being filed against Janssen in courts around the U.S. In December 2016, federal lawsuits involving Invokana were centralized in a multi-district litigation (“MDL”) before U.S. District Court Judge Brian R. Martinotti in the United States District Court for the District of New Jersey. Judge Martinoti plans to select three cases for the first bellwether trials which will begin in September 2018.
Plaintiffs in Invokana lawsuits claim that Janssen concealed important safety information about the drug and did not test it adequately before putting it on the market. The lawsuits allege that had plaintiffs been warned about these risks, they could have chosen an alternative method of treating their Type 2 diabetes. Plaintiffs further contend that Janssen has failed to adequately warn physicians and patients about the extent of the risk of diabetic ketoacidosis as well as leg, foot, and finger amputations putting the company’s profits above patient safety.
Maine Invokana Lawsuit
If you or someone you love has suffered complications from Invokana, you may be entitled to significant compensation for your injuries, including pain and suffering, past and future medical treatment, lost wages, loss of earning capacity, loss of enjoyment or quality of life, emotional distress, loss of consortium, and wrongful death.
To speak with an experienced, Maine Invokana lawyer, contact a prescription drug attorney at Fitzgerald Law Group at (844) FITZ-LAW or (844) 348-9529, or complete the contact form on this website for a free, confidential, case assessment.